Back to Search
Start Over
Molecular Mechanisms and Therapeutic Strategies of Chronic Renal Injury: The Role of Nuclear Factor κB Activation in the Development of Renal Fibrosis
- Source :
- Journal of Pharmacological Sciences, Vol 100, Iss 1, Pp 17-21 (2006)
- Publication Year :
- 2006
- Publisher :
- Japanese Pharmacological Society, 2006.
-
Abstract
- Tubulointerstitial fibrosis is a common feature of many progressive renal diseases and is a main determinant that leads to an irreversible loss of renal function. In chronic cyclosporin A nephrotoxicity, we previously reported that inflammatory responses such as macrophage infiltration preceded interstitial fibrosis. This inflammation was accompanied by an elevation in renal nuclear factor κB (NF-κB) activity. Similar findings were obtained in chronic tacrolimus nephrotoxicity and obstructive nephropathy. Inhibition of NF-κB markedly attenuated renal inflammation and interstitial fibrosis in these models. Furthermore, administration of oral adsorbent (Kremezin®) significantly attenuated the increase in renal NF-κB activity and concomitantly reduced interstitial inflammation and renal fibrosis in chronic renal failure rats. Elimination of indoxyl sulfate by this adsorbent is likely involved in this mechanism since it is known that indoxyl sulfate activates NF-κB in renal tubular cells. It is suggested that strategy aiming at NF-κB inhibition is important to prevent the progression of renal fibrosis. Keywords:: nuclear factor κB, renal fibrosis, nephrotoxicity, unilateral ureteral obstruction, oral adsorbent
- Subjects :
- medicine.medical_specialty
Pyrrolidines
Anti-Inflammatory Agents
Renal function
Inflammation
Pharmacology
urologic and male genital diseases
Nephrotoxicity
Renin-Angiotensin System
Thiocarbamates
Fibrosis
Internal medicine
medicine
Renal fibrosis
Animals
business.industry
lcsh:RM1-950
NF-kappa B
Oxides
medicine.disease
Carbon
Obstructive Nephropathy
Tacrolimus
Rats
Disease Models, Animal
lcsh:Therapeutics. Pharmacology
Endocrinology
Tubulointerstitial fibrosis
Molecular Medicine
Kidney Diseases
medicine.symptom
business
Angiotensin II Type 1 Receptor Blockers
Subjects
Details
- ISSN :
- 13478648 and 13478613
- Volume :
- 100
- Database :
- OpenAIRE
- Journal :
- Journal of Pharmacological Sciences
- Accession number :
- edsair.doi.dedup.....a9ad3a5940fd6ea52f23ec37116d5542
- Full Text :
- https://doi.org/10.1254/jphs.fmj05003x4